Filing Details
- Accession Number:
- 0001658918-26-000014
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2026-07-17 21:46:47
- Reporting Period:
- 2026-07-15
- Filing Date:
- 2026-07-17
- Accepted Time:
- 2026-07-17 21:46:47
- SEC Url:
- Form 4 Filing
- 10b5-1 trading plan:
- Unchecked
The filer left the 10b5-1 checkbox unchecked. This is not proof that every trade was unplanned.
A 10b5-1 plan sets trading instructions in advance, so trades follow those instructions instead of a new decision at the time of each trade. The checkbox applies to the filing as a whole and does not identify every covered trade; see the footnotes for details. It reflects the filer's disclosure, not SEC approval of the plan. SEC Form 4 instructions.
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1770069 | Maplight Therapeutics Inc. | MPLT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1658918 | A. Christopher Kroeger | C/O Maplight Therapeutics, Inc. 800 Chesapeake Drive Redwood City CA 94063 | Chief Executive Officer | No | No | No | No |
Transaction Summary
| Sold: | 147,639 shares | Avg. Price: $36.87 | Total Value: $5,443,721.84 |
| Number of Shares After Transactions: | 1,246,455 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Voting Common Stock | Disposition | 2026-07-15 | 18,950 | $36.00 | 1,375,144 | No | 4 | S | Direct | |
| Voting Common Stock | Disposition | 2026-07-15 | 42,738 | $36.99 | 1,332,406 | No | 4 | S | Direct | |
| Voting Common Stock | Disposition | 2026-07-15 | 90 | $37.54 | 1,332,316 | No | 4 | S | Direct | |
| Voting Common Stock | Disposition | 2026-07-16 | 40,899 | $36.46 | 1,291,417 | No | 4 | S | Direct | |
| Voting Common Stock | Disposition | 2026-07-16 | 28,091 | $37.26 | 1,263,326 | No | 4 | S | Direct | |
| Voting Common Stock | Disposition | 2026-07-16 | 92 | $37.96 | 1,263,234 | No | 4 | S | Direct | |
| Voting Common Stock | Disposition | 2026-07-17 | 16,779 | $37.90 | 1,246,455 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Voting Common Stock | 101,190 | Indirect | See footnote |
Footnotes
- Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.5338 to $36.5273 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.53 to $37.405 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.9075 to $36.9013 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.9082 to $37.89 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.49 to $37.925 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The shares are held by the C&M Kroeger Nominee Trust, of which the Reporting Person is co-trustee with his spouse and has voting and dispositive power.